News

Research with Impact-Dr. PJ Devereaux

  • December 9, 2015
  • News

A series of articles has been created by HHS Research which shine the spotlight on studies published in 2014 with an HHS Researcher as lead author. Each piece features a study published in a journal with an Impact factor greater than 10 and provides information about the author and about the research they lead. If their work strikes a cord with you, Tweet us at @HamHealthSc and include hashtag: HHSResearch

Dr. PJ Devereaux FRCPC received his BSc at Dalhousie, then his MD/ PhD in Clinical Epidemiology at McMaster University. After medical school, he completed a residency in internal medicine at the University of Calgary and a residency in cardiology at Dalhousie University.  Dr Devereaux is a Professor in the Department of Clinical Epidemiology and Biostatistics and the Division of Cardiology, Department of Medicine at McMaster University. Dr. Devereaux is Co-Principal Investigator of the POISE trial; the world’s largest cardiac randomized controlled trial in patients undergoing non-cardiac surgery. He is the Head of Cardiology and the Perioperative Cardiovascular Clinical Program at the Juravinski Hospital and Cancer Centre. He is also the Scientific Leader of the Anesthesiology, Perioperative Medicine, and Surgical Research Group at the Population Health Research Institute. His interests include clinical research in perioperative vascular medicine in patients undergoing noncardiac surgery. Dr. Devereaux has published over 180 peer reviewed papers and 40 editorials, book chapters, and commentaries.

Devereaux

Publication:

Devereaux, P. J., Guyatt, G., Cook, D., Eikelboom, J., LeManach, Y., Pogue, J., Whitlock, R., Lamy, A., Kearon, C., Yusuf, S. (2014). Aspirin in patients undergoing non-cardiac surgery. New England Journal of Medicine, 370, 1494-1503.

Background of study: There is substantial variability in the perioperative administration of aspirin in patients undergoing noncardiac surgery, both among patients who are already on an aspirin regimen and among those who are not.

Conclusion: Administration of aspirin before surgery and throughout the early postsurgical period had no significant effect on the rate of a composite of death or nonfatal myocardial infarction but increased the risk of major bleeding